Related Experiment Video

Updated: Aug 30, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
07:21

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

Estrogen-dependent inherited angioedema

Karen E Binkley1, Alvin E Davis

  • 1Department of Medicine, Division of Clinical Immunology and Allergy, University of Toronto, Toronto, Canada. tbowen@pol.net

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
|October 24, 2003
PubMed

Insights

Hereditary angioedema involves recurrent swelling episodes, often linked to C1 inhibitor deficiency. Androgens can increase C1 inhibitor levels and reduce attacks, offering a potential therapy for this condition.

Area of Science:

  • Immunology
  • Genetics
  • Endocrinology

Background:

  • Hereditary angioedema (HAE) presents with recurrent swelling episodes.
  • Biochemically, HAE is associated with reduced C1 inhibitor (C1-INH) levels or function.
  • Genetically, HAE is linked to mutations in the C1 inhibitor gene with autosomal dominant inheritance.

Purpose of the Study:

  • To explore the clinical effects of androgens and estrogens in hereditary angioedema patients.
  • To investigate the mechanisms underlying sex steroid hormone influence on C1 inhibitor protein levels.
  • To understand the pathogenesis and treatment of both classic and estrogen-dependent angioedema.

Main Methods:

  • Clinical observation of hereditary angioedema patients.
  • Biochemical analysis of C1 inhibitor levels and function.
  • Genetic analysis of C1 inhibitor gene mutations.
  • Review of hormonal therapy effects, including androgens and estrogens.

Main Results:

  • Androgens demonstrate a therapeutic effect by increasing C1 inhibitor protein levels.
  • Androgen administration is associated with a reduction in angioedema attacks.
  • Estrogens may have an antagonistic effect on C1 inhibitor protein levels.

Conclusions:

  • Androgens represent an important therapeutic strategy for hereditary angioedema by modulating C1 inhibitor levels.
  • The mechanisms of sex steroid hormone action in HAE remain largely unknown.
  • A novel estrogen-dependent form of angioedema may provide insights into hormone-related HAE pathogenesis and treatment.

More Related Videos

Imaging of Estrogen Receptor-α in Rat Pial Arterioles using a Digital Immunofluorescent Microscope07:42

Imaging of Estrogen Receptor-α in Rat Pial Arterioles using a Digital Immunofluorescent Microscope

Published on: November 29, 2011

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis06:12

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

Published on: June 24, 2019

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...